Search Results 371-380 of 13267 for Assay
GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...
Our lab team has been identifying biomarkers and developing assays ... In addition, our lab is creating a highly multiplexed mass spectrometry-based lipidomic ...
... assay, laboratory, or database infrastructure. “Genomics is reaching an inflection point in cost, volumes, and knowledge, creating a significant opportunity ...
... assayed from blood of cases with CAP and controls without history of cancer. Participation eligibility. Participant eligibility includes age, gender, type ...
Researchers in the laboratory are developing new advanced diagnostic assays. This includes multi-omic analyses, which is the combination of metagenomics ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. Pagination Clinical studies. Prev ...
Since introduction of live transfected cell-based assays, myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) has emerged as a reproducible ...
... Assay. Arch Pathol Lab Med. 2024 Jul 1; 148 (7):818-827. View PubMed; Rifai N, Meredith W, Brown K, Erdahl SA, Jannetto PJ. High Lead Levels in 2 Independent ...
The purpose of this study is to develop an RNA-seq based peripheral blood assay predictive of inflammation/rejection on allograft biopsy in adult heart ...
Notably, patients without prior treatment exhibited the highest incidence of this mutation, suggesting that for optimal yield, ctDNA assays should be performed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.